4.5 Article

Structure-Based Design of ASK1 Inhibitors as Potential Agents for Heart Failure

期刊

ACS MEDICINAL CHEMISTRY LETTERS
卷 8, 期 3, 页码 316-320

出版社

AMER CHEMICAL SOC
DOI: 10.1021/acsmedchemlett.6b00481

关键词

Apoptosis signal-regulating kinase 1 (ASK1); structure-based drug design (SBDD); cardiac injury

资金

  1. Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy [DE-AC02-05CH11231]
  2. DOE Office of Science [DE-AC02-06CH11357]

向作者/读者索取更多资源

Apoptosis signal-regulating kinase 1 (ASK1/ MAP3K) is a mitogen-activated protein kinase family member shown to contribute to acute ischemia/reperfusion injury. Using structure-based drug design, deconstruction, and reoptimization of a known ASK1 inhibitor, a lead compound was identified. This compound displayed robust MAP3K pathway inhibition and reduction of infarct size in an isolated perfused heart model of cardiac injury.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据